Consolidated Balance Sheets - USD ($)	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 3,258,058	$ 2,977,713
Marketable securities	0	2,976,573
Accounts receivable, net of allowance for credit losses of $10,000, respectively	475,376	312,664
Prepaid expenses and other current assets	564,645	517,785
Inventories	3,713,215	2,638,186
Advances on contracts	1,275,260	1,371,548
Total current assets	9,286,554	10,794,469
Furniture, fixtures and equipment, net	12,921	10,024
Intangibles, net	148,404	178,636
Right of use assets finance lease	67,201	8,998
Right of use assets operating lease	257,842	355,235
Other assets	24,150	24,150
Total assets	9,797,072	11,371,512
Current liabilities:
Accrued expenses and other payables	1,796,319	1,511,717
Accrued expenses, related party	304,293	137,189
Accrued liabilities noncontrolling interest	0	214,000
Current portion of finance lease liabilities	12,530	10,264
Current portion of operating lease liabilities	116,279	103,427
Total current liabilities	3,744,127	3,076,713
Non-current portion of finance lease liabilities	54,672	434
Non-current portion of operating lease liabilities	165,573	281,853
Total liabilities	3,964,372	3,359,000
Commitments and contingencies
Stockholders’ equity
Common stock, par value $0.001; authorized 100,000,000 shares; 78,047,798 shares issued and 78,014,465 shares outstanding as of December 31, 2024; 75,881,840 shares issued and 75,848,507 shares outstanding as of December 31, 2023;	78,048	75,881
Additional paid in capital	134,719,274	132,187,656
Accumulated deficit	(128,053,106)	(123,339,509)
Treasury stock, at cost, 33,333 shares	(911,516)	(911,516)
Total Milestone Scientific, Inc. stockholders' equity	5,832,700	8,012,512
Total liabilities and stockholders’ equity	9,797,072	11,371,512
Nonrelated Party [Member]
Current liabilities:
Accounts payable	1,021,393	689,604
Related Party [Member]
Current liabilities:
Accounts payable	$ 493,313	$ 410,512